Abstract: A shaving razor that improves stability, corresponding user control and offers a closer shave is provided. The shaving razor can include a razor handle configuration that reduces the propensity for the shaving razor to roll in a users hand and improves the maneuverability of the razor cartridge during shaving. In addition, the shaving razor can include a biasing pivoting member producing a progressively increasing return torque on the razor cartridge that forces the cartridge into flat contact with the skin thus improving glide and shaving closeness.

Abstract: A shaving razor that offers a closer shave is provided. The shaving razor can include a biasing member producing a progressively increasing return torque on the razor cartridge that forces the cartridge into flat contact with the skin as the cartridge pivots, thus improving glide and shaving closeness. In addition, the shaving razor can include a razor handle configuration that reduces the propensity for the shaving razor to roll in a user's hand and improves the maneuverability of the razor cartridge during shaving.

Abstract: Described are crystalline forms of the pharmaceutical compound “[9S-(9?,10?,12?)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3?,2?,1?-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester”, as well as methods for their use and preparation.

Abstract: A shaving razor that improves stability, corresponding user control and offers a closer shave is provided. The shaving razor can include a razor handle configuration that reduces the propensity for the shaving razor to roll in a user's hand and improves the maneuverability of the razor cartridge during shaving. In addition, the shaving razor can include a biasing pivoting member producing a progressively increasing return torque on the razor cartridge that forces the cartridge into flat contact with the skin thus improving glide and shaving closeness.

Abstract: A linkage mechanism for a wet shaving razor is provided. The linkage mechanism is pivotally connected to and suspended from the handle at one end and pivotally and removably attached to the cartridge carrier at an opposite end allowing the cartridge carrier to pivot about a virtual pivot axis located below the shaving plane and into the skin. The linkage mechanism provides flexibility in positioning the virtual pivot axis since it is not limited to the physical constraints of the cartridge. As a result, the shaving razor cartridge has a flatter contact with the skin throughout the shaving stroke providing shaving comfort with reduced nicks and cuts.

Abstract: A razor blade assembly having a razor cartridge connected to a handle via a pivoting mechanism. The razor cartridge rotates about a virtual pivot axis produced by the pivoting mechanism. The virtual pivot axis is positioned in a virtual pivot axis region located forward of the cartridge midpoint toward the front edge of the cartridge and into the skin.

Abstract: A razor blade assembly connected to a handle via a linkage mechanism is provided including a razor cartridge that rotates about a virtual pivot axis. The linkage mechanism is suspended from the handle for rotating the cartridge about the virtual pivot axis. The virtual pivot axis is positioned in a virtual pivot axis region located forward of the cartridge midpoint toward the front edge of the cartridge and into the skin. The virtual pivot axis region is defined by a first boundary and a second boundary.

Abstract: A razor cartridge has a housing, a guard located at a front of the housing and a cap located at a rear of the housing. A skin contact element is disposed in the housing partway between the guard and the cap. A skin contact plane defines a plane tangential to the guard and the skin contact element and a plane tangential to the skin contact element and the cap. One or more blades are located between the guard and the skin contact element, each of the blades having a cutting edge located at a distance y1 between 70 ?m and 300 ?m and at an angle ?1 between 20° and 45° below the skin contact plane. One or more blades are located between the skin contact element and the cap, each of the blades having a cutting edge located at an angle ?2 above or below the skin contact plane, wherein ?2 is lower in magnitude than ?1.

Abstract: A method of performing a single step/single solvent edge bead removal (EBR) process on a photolithography layer stack including a photoresist layer and a top coat layer using propylene glycol monomethyl ether acetate (PGMEA) or a mixture of PGMEA and gamma-butyrolactone (GBL) is disclosed. The single step/single solvent EBR process is compatible with organic and inorganic BARC layers.

Abstract: Methods for the preparation of 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and salts thereof are described.

Abstract: A shaving razor that improves stability, corresponding user control and offers a closer shave is provided. The shaving razor can include a razor handle configuration that reduces the propensity for the shaving razor to roll in a user's hand and improves the maneuverability of the razor cartridge during shaving. In addition, the shaving razor can include a biasing pivoting member producing a progressively increasing return torque on the razor cartridge that forces the cartridge into flat contact with the skin thus improving glide and shaving closeness.

Abstract: A shaving razor that improves stability, corresponding user control and offers a closer shave is provided. The shaving razor can include a razor handle configuration that reduces the propensity for the shaving razor to roll in a users hand and improves the maneuverability of the razor cartridge during shaving. In addition, the shaving razor can include a biasing pivoting member producing a progressively increasing return torque on the razor cartridge that forces the cartridge into flat contact with the skin thus improving glide and shaving closeness.

Abstract: A shaving razor that offers a closer shave is provided. The shaving razor can include a biasing member producing a progressively increasing return torque on the razor cartridge that forces the cartridge into flat contact with the skin as the cartridge pivots, thus improving glide and shaving closeness. In addition, the shaving razor can include a razor handle configuration that reduces the propensity for the shaving razor to roll in a user's hand and improves the maneuverability of the razor cartridge during shaving.

Abstract: Described are crystalline forms of the pharmaceutical compound “[9S-(9?,10?,12?)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9, 12-epoxy-1H-diindolo[1,2,3-fg:3?,2?,1?-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester”, as well as methods for their use and preparation.

Abstract: 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine hydrogen malonate salt and pharmaceutical comprising and uses of the same, including for the treatment of schizophrenia and other psychotic disorders are described.

Abstract: The subject invention improves traditional safety equipment intended to protect the lower leg, ankle, foot, and toes applicable in industrial and commercial as well as casual and athletic uses. The personal protective equipment (PPE) of the subject invention comprises a soleplate, a metatarsal component, a toe cap, and a tibia-fibula component; these components can be implemented alone or in combination within a shoe or boot providing for various levels of protection depending on the desired application. Further embodiments provide for both the implementation of the protective components within the footwear as well as components that can be worn in conjunction with pre-existing shoes or boots.

Abstract: Described are crystalline forms of the pharmaceutical compound “[9S-(9?,10?,12?)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3 -fg:3?,2?,1?-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester”, as well as methods for their use and preparation.

Abstract: 4-((1R,35)-6-Chloro-3 -phenylindan-1-yl)-1,2,2-trimethylpiperazine hydrogen malonate salt and pharmaceutical comprising and uses of the same, including for the treatment of schizophrenia and other psychotic disorders are described.

Abstract: Methods for the preparation of 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and salts thereof are described.

Abstract: A compound 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-2,2-dimethylpiperazine and salts thereof, pharmaceutical compositions comprising the compound and salts, and medical use thereof, including for treatment of schizophrenia and other psychotic disorders.